Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterizing malignant prognostic signatures in primary glioma based on single-cell and bulk transcriptome sequencing. | PLoS One | 2026 | 42247404 | PubTator, text mining | PubMed |
| The exploration to identify key molecules in the interaction between endothelial cells and mono-macrophages in atherosclerosis based on the single cell transcriptome. | BMC Cardiovasc Disord | 2026 | 42243679 | PubTator, text mining | PubMed |
| Targeted extracellular vesicle-photoimmunotherapy remodels stromal-immune microenvironment to boost chemo-immunotherapy in preclinical models. | Cell Rep Med | 2026 | 42235518 | PubTator, text mining | PubMed |
| SLC10A3 drives glioblastoma progression by remodeling the immunosuppressive microenvironment and promoting M2 macrophage migration. | Front Oncol | 2026 | 42211491 | PubTator, text mining | PubMed |
| Serum Midkine as a Biomarker for Hepatocellular Carcinoma Treatment Response and Prognostication. | J Clin Lab Anal | 2026 | 42184120 | PubTator, text mining | PubMed |
| Evidence of the role of Midkine and Pleiotrophin in the pathogenesis of Familial Mediterranean Fever. | Eur J Pediatr | 2026 | 42149205 | PubTator, text mining | PubMed |
| Repurposing Resmetirom to Suppress MASLD/MASH-HCC in the Dysmetabolic Era. | Oncol Ther | 2026 | 42141212 | PubTator, text mining | PubMed |
| Integrating spatial and single-cell transcriptomics via machine learning to characterize efferocytosis in hepatocellular carcinoma prognosis and immunotherapy. | Transl Oncol | 2026 | 42140032 | PubTator, text mining | PubMed |
| Exploring key biomarkers associated with axillary lymph node metastasis in breast cancer using single-cell RNA sequencing and Mendelian randomization. | Int J Biol Markers | 2026 | 42121358 | PubTator, text mining | PubMed |
| Heparan Sulphate Glycosaminoglycan Chains Contribute to the Tethering of Coronal Factors and Are Important for Extracellular Vesicle-Mediated Fibroblast Activation. | J Extracell Biol | 2026 | 42116937 | PubTator, text mining | PubMed |
| Single-cell and bulk omics uncover fibroblast heterogeneity and HSPH1 as a key driver in Barrett's esophagus to esophageal adenocarcinoma progression. | Cancer Cell Int | 2026 | 42108450 | PubTator, text mining | PubMed |
| Impaired Midkine/Treg Signaling Contributes to Pathogenesis of Preeclampsia. | Hypertension | 2026 | 42100812 | PubTator, text mining | PubMed |
| MDK Activates the PI3K/AKT Axis to Induce AP2A1 Expression and Epithelial-Mesenchymal Transition in Colorectal Cancer. | Cancers (Basel) | 2026 | 42073635 | PubTator, text mining | PubMed |
| Evaluation of correlation of GDF11 and atherogenic factors in patients with diabetic dyslipidemia. | Pol Merkur Lekarski | 2026 | 42048502 | PubTator, text mining | PubMed |
| Oncogenic overexpression of kallikrein-related peptidase 7 is associated with the progression of thyroid cancer. | Histochem Cell Biol | 2026 | 42017987 | PubTator, text mining | PubMed |
| Single-Cell Sequencing Plus Spatial Transcriptomics: Dissecting Tumor Heterogeneity, Immunosuppression, and Potential Targets for ASPSCR1::TFE3 Renal Cell Carcinoma. | Am J Pathol | 2026 | 42009247 | PubTator, text mining | PubMed |
| Rewiring immunity: Midkine's emerging role in cancer immune escape and drug resistance. | iScience | 2026 | 42004035 | PubTator, text mining | PubMed |
| Identification of Drug-resistant Cell Subpopulations in Colorectal Cancer Through Single-cell Analysis and Exploration of Potential Therapeutic Strategies. | Curr Med Chem | 2026 | 42003098 | PubTator, text mining | PubMed |
| Midkine as a novel prognostic and therapeutic target in meningioma: insights from single-cell analysis and organoid-based drug validation. | J Transl Med | 2026 | 41981656 | PubTator, text mining | PubMed |
| Cross-species single-cell transcriptomic analyses reveal evolutionary conservation and diversification of ovarian tissues. | J Anim Sci Biotechnol | 2026 | 41975518 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=3